We integrate our deep science capabilities and cutting-edge technology to develop innovative, accessible and affordable therapies for patients worldwide.
We integrate our deep science capabilities and cutting-edge technology to develop innovative, accessible and affordable therapies for patients worldwide.
We are a science-driven, innovation-focused pharmaceutical company committed to accelerating access to healthcare solutions to patients around the world. While our 22 manufacturing units cater to patient needs across continents, our 8 global R&D centres are pushing the boundaries of science to develop innovative and effective cures for patients. We are committed to R&D investments in technologies to improve the environmental and social impact of products and processes such as the design, development and implementation of processes to reduce or eliminate hazardous substances
- 1,071 patents filed (As of FY22)
- More than 1,000 papers published (As of FY22)
Our R&D focus
At the core of our R&D prowess is the Integrated Product Development Organisation (IPDO), at Bachupally, Hyderabad, India. The expansive campus of IPDO houses several laboratories with the most recent being the Nutraceutical R&D centre. These labs, powered by a diverse talent pool of scientists from leading institutions around the world.
Our product development efforts drive a portfolio of more than 1,000 products enabled by our robust R&D team consisting of more than 150 doctorates.
Future focus
We run pioneering projects at the cutting edge of drug development across all technologies and dosage forms. Our team has expertise across therapeutic areas and geographies for generics as well as APIs, biosimilars, OTC drugs and other differentiated products.
Along with our deep and diverse expertise across chemistry, engineering, biology and formulations, we are also exploring advanced manufacturing technologies, measurement, analytics & controls, modelling & simulation and digital innovation.
In short, our R&D capabilities play a key role in fulfilling our promise of addressing unmet patient needs, bringing expensive medicines within reach and helping patients manage disease better.
Digital Science
Our Digital science initiative helps give impetus to our Research and Development effort with data and analytics use cases across the development cycle. These use cases are aimed at achieving significant reduction in drug development cycle time, improvement of bio study success rate, cost savings to enable First-to-Market products, accelerating the R&D timeline, etc.
